HEADER LIGASE 15-MAR-22 7Z77 TITLE CRYSTAL STRUCTURE OF COMPOUND 6 IN COMPLEX WITH THE BROMODOMAIN OF TITLE 2 HUMAN SMARCA2 AND PVHL:ELONGINC:ELONGINB COMPND MOL_ID: 1; COMPND 2 MOLECULE: ELONGIN-B; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ELOB,ELONGIN 18 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 5 FACTOR SIII SUBUNIT B,SIII P18,TRANSCRIPTION ELONGATION FACTOR B COMPND 6 POLYPEPTIDE 2; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ELONGIN-C; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: ELOC,ELONGIN 15 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 12 FACTOR SIII SUBUNIT C,SIII P15,TRANSCRIPTION ELONGATION FACTOR B COMPND 13 POLYPEPTIDE 1; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR; COMPND 17 CHAIN: C; COMPND 18 SYNONYM: PROTEIN G7,PVHL; COMPND 19 ENGINEERED: YES; COMPND 20 MOL_ID: 4; COMPND 21 MOLECULE: PROBABLE GLOBAL TRANSCRIPTION ACTIVATOR SNF2L2; COMPND 22 CHAIN: D; COMPND 23 SYNONYM: ATP-DEPENDENT HELICASE SMARCA2,BRG1-ASSOCIATED FACTOR 190B, COMPND 24 BAF190B,PROTEIN BRAHMA HOMOLOG,HBRM,SNF2-ALPHA,SWI/SNF-RELATED COMPND 25 MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY A COMPND 26 MEMBER 2; COMPND 27 EC: 3.6.4.-; COMPND 28 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ELOB, TCEB2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: ELOC, TCEB1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: VHL; SOURCE 20 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 22 MOL_ID: 4; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606; SOURCE 26 GENE: SMARCA2, BAF190B, BRM, SNF2A, SNF2L2; SOURCE 27 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 28 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTAC, COMPLEX, BROMODOMAIN, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR G.BADER,J.BOETTCHER,B.WOLKERSTORFER REVDAT 3 31-JAN-24 7Z77 1 REMARK REVDAT 2 26-OCT-22 7Z77 1 JRNL REVDAT 1 14-SEP-22 7Z77 0 JRNL AUTH C.KOFINK,N.TRAINOR,B.MAIR,S.WOHRLE,M.WURM,N.MISCHERIKOW, JRNL AUTH 2 M.J.ROY,G.BADER,P.GREB,G.GARAVEL,E.DIERS,R.MCLENNAN, JRNL AUTH 3 C.WHITWORTH,V.VETMA,K.RUMPEL,M.SCHARNWEBER,J.E.FUCHS, JRNL AUTH 4 T.GERSTBERGER,Y.CUI,G.GREMEL,P.CHETTA,S.HOPF,N.BUDANO, JRNL AUTH 5 J.RINNENTHAL,G.GMASCHITZ,M.MAYER,M.KOEGL,A.CIULLI, JRNL AUTH 6 H.WEINSTABL,W.FARNABY JRNL TITL A SELECTIVE AND ORALLY BIOAVAILABLE VHL-RECRUITING PROTAC JRNL TITL 2 ACHIEVES SMARCA2 DEGRADATION IN VIVO. JRNL REF NAT COMMUN V. 13 5969 2022 JRNL REFN ESSN 2041-1723 JRNL PMID 36216795 JRNL DOI 10.1038/S41467-022-33430-6 REMARK 2 REMARK 2 RESOLUTION. 1.97 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 59.7 REMARK 3 NUMBER OF REFLECTIONS : 23493 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1194 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.16 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 5.07 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 470 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2372 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 452 REMARK 3 BIN R VALUE (WORKING SET) : 0.2363 REMARK 3 BIN FREE R VALUE : 0.2634 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.83 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 18 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3706 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 69 REMARK 3 SOLVENT ATOMS : 100 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.93550 REMARK 3 B22 (A**2) : -0.15030 REMARK 3 B33 (A**2) : -0.78520 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.94940 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.330 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.331 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.232 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.922 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 7669 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 13923 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1702 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1167 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 7669 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 497 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7982 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 0.98 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.08 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.52 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 9.1272 23.2955 25.4552 REMARK 3 T TENSOR REMARK 3 T11: 0.0063 T22: -0.0126 REMARK 3 T33: -0.0159 T12: 0.0530 REMARK 3 T13: -0.0360 T23: -0.0227 REMARK 3 L TENSOR REMARK 3 L11: 0.2585 L22: 0.6028 REMARK 3 L33: 0.2691 L12: -0.4391 REMARK 3 L13: 0.5061 L23: -0.2538 REMARK 3 S TENSOR REMARK 3 S11: 0.0013 S12: 0.0099 S13: 0.0140 REMARK 3 S21: -0.0216 S22: -0.0015 S23: -0.0157 REMARK 3 S31: -0.0183 S32: -0.0052 S33: 0.0002 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 14.7820 10.2003 36.0369 REMARK 3 T TENSOR REMARK 3 T11: -0.0247 T22: -0.0061 REMARK 3 T33: 0.0182 T12: 0.0092 REMARK 3 T13: -0.0052 T23: -0.0364 REMARK 3 L TENSOR REMARK 3 L11: 0.5543 L22: 0.6755 REMARK 3 L33: 0.3074 L12: -0.6954 REMARK 3 L13: -0.0165 L23: 0.2096 REMARK 3 S TENSOR REMARK 3 S11: -0.0020 S12: -0.0132 S13: -0.0088 REMARK 3 S21: 0.0167 S22: 0.0002 S23: -0.0014 REMARK 3 S31: -0.0056 S32: -0.0113 S33: 0.0018 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { C|* } REMARK 3 ORIGIN FOR THE GROUP (A): 25.8678 -12.7374 24.9336 REMARK 3 T TENSOR REMARK 3 T11: 0.0046 T22: -0.0319 REMARK 3 T33: -0.0346 T12: 0.0398 REMARK 3 T13: 0.0284 T23: -0.0006 REMARK 3 L TENSOR REMARK 3 L11: 0.4408 L22: 0.8080 REMARK 3 L33: 0.9955 L12: -0.1095 REMARK 3 L13: -0.1705 L23: 0.6687 REMARK 3 S TENSOR REMARK 3 S11: -0.0181 S12: -0.0265 S13: 0.0170 REMARK 3 S21: -0.0198 S22: -0.0031 S23: -0.0147 REMARK 3 S31: 0.0764 S32: 0.0084 S33: 0.0212 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: { D|* } REMARK 3 ORIGIN FOR THE GROUP (A): 40.5365 -37.2060 -0.3322 REMARK 3 T TENSOR REMARK 3 T11: -0.0073 T22: 0.0213 REMARK 3 T33: -0.0737 T12: 0.0530 REMARK 3 T13: -0.0052 T23: 0.0290 REMARK 3 L TENSOR REMARK 3 L11: 0.2026 L22: 0.5805 REMARK 3 L33: 1.4535 L12: -0.6279 REMARK 3 L13: 0.1382 L23: -0.2271 REMARK 3 S TENSOR REMARK 3 S11: -0.0041 S12: 0.0068 S13: 0.0109 REMARK 3 S21: 0.0179 S22: -0.0020 S23: -0.0030 REMARK 3 S31: -0.0048 S32: 0.0221 S33: 0.0061 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7Z77 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1292121721. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-JUL-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : STARANISO 2.2.19 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29493 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.970 REMARK 200 RESOLUTION RANGE LOW (A) : 90.170 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.7 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.97 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: 5T35, 4QY4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 % PEG 3350, 0.1 M BIS_TRIS PROPANE REMARK 280 PH 7.5, 200 MM SODIUM FORMATE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.85350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 47 REMARK 465 GLY B 48 REMARK 465 PRO B 49 REMARK 465 GLY B 50 REMARK 465 GLN B 51 REMARK 465 PHE B 52 REMARK 465 ALA B 53 REMARK 465 GLU B 54 REMARK 465 ASN B 55 REMARK 465 GLU B 56 REMARK 465 GLY C 52 REMARK 465 SER C 53 REMARK 465 MET C 54 REMARK 465 GLU C 55 REMARK 465 ALA C 56 REMARK 465 GLY C 57 REMARK 465 ARG C 58 REMARK 465 PRO C 59 REMARK 465 MET C 211 REMARK 465 GLY C 212 REMARK 465 ASP C 213 REMARK 465 SER D 1371 REMARK 465 MET D 1372 REMARK 465 ALA D 1373 REMARK 465 GLU D 1374 REMARK 465 LYS D 1375 REMARK 465 GLU D 1491 REMARK 465 GLU D 1492 REMARK 465 GLU D 1493 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 10 -118.53 55.80 REMARK 500 ASP A 47 -96.79 67.20 REMARK 500 ALA A 71 68.83 -156.81 REMARK 500 ASP A 82 -95.30 61.59 REMARK 500 ASN B 58 27.74 -142.60 REMARK 500 GLU B 89 124.27 3.56 REMARK 500 ASN C 90 -169.77 -72.90 REMARK 500 SER C 139 -163.20 -100.20 REMARK 500 ASP C 143 79.71 54.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7Z76 RELATED DB: PDB REMARK 900 RELATED ID: 7Z6L RELATED DB: PDB DBREF 7Z77 A 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 7Z77 B 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 7Z77 C 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 7Z77 D 1373 1493 UNP P51531 SMCA2_HUMAN 1373 1493 SEQADV 7Z77 MET B 16 UNP Q15369 INITIATING METHIONINE SEQADV 7Z77 GLY C 52 UNP P40337 EXPRESSION TAG SEQADV 7Z77 SER C 53 UNP P40337 EXPRESSION TAG SEQADV 7Z77 SER D 1371 UNP P51531 EXPRESSION TAG SEQADV 7Z77 MET D 1372 UNP P51531 EXPRESSION TAG SEQRES 1 A 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 A 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 A 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 A 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 A 104 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 A 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 A 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 A 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 B 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 B 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 B 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 B 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 B 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 B 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 B 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 B 97 ALA ASN PHE LEU ASP CYS SEQRES 1 C 162 GLY SER MET GLU ALA GLY ARG PRO ARG PRO VAL LEU ARG SEQRES 2 C 162 SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE CYS SEQRES 3 C 162 ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU ASN SEQRES 4 C 162 PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO PRO SEQRES 5 C 162 GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS LEU SEQRES 6 C 162 TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU LEU SEQRES 7 C 162 VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN VAL SEQRES 8 C 162 ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO VAL SEQRES 9 C 162 TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SER SEQRES 10 C 162 LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE VAL SEQRES 11 C 162 ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN VAL SEQRES 12 C 162 GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE ALA SEQRES 13 C 162 HIS GLN ARG MET GLY ASP SEQRES 1 D 123 SER MET ALA GLU LYS LEU SER PRO ASN PRO PRO LYS LEU SEQRES 2 D 123 THR LYS GLN MET ASN ALA ILE ILE ASP THR VAL ILE ASN SEQRES 3 D 123 TYR LYS ASP SER SER GLY ARG GLN LEU SER GLU VAL PHE SEQRES 4 D 123 ILE GLN LEU PRO SER ARG LYS GLU LEU PRO GLU TYR TYR SEQRES 5 D 123 GLU LEU ILE ARG LYS PRO VAL ASP PHE LYS LYS ILE LYS SEQRES 6 D 123 GLU ARG ILE ARG ASN HIS LYS TYR ARG SER LEU GLY ASP SEQRES 7 D 123 LEU GLU LYS ASP VAL MET LEU LEU CYS HIS ASN ALA GLN SEQRES 8 D 123 THR PHE ASN LEU GLU GLY SER GLN ILE TYR GLU ASP SER SEQRES 9 D 123 ILE VAL LEU GLN SER VAL PHE LYS SER ALA ARG GLN LYS SEQRES 10 D 123 ILE ALA LYS GLU GLU GLU HET IFF C1501 131 HETNAM IFF (2~{S},4~{R})-~{N}-[(1~{S})-4-[4-(4-BROMANYL-7- HETNAM 2 IFF CYCLOPENTYL-5-OXIDANYLIDENE-BENZIMIDAZOLO[1,2- HETNAM 3 IFF A]QUINAZOLIN-9-YL)PIPERIDIN-1-YL]-1-[4-(4-METHYL-1,3- HETNAM 4 IFF THIAZOL-5-YL)PHENYL]BUTYL]-1-[(2~{S})-2-[(1- HETNAM 5 IFF FLUORANYLCYCLOPROPYL)CARBONYLAMINO]-3,3-DIMETHYL- HETNAM 6 IFF BUTANOYL]-4-OXIDANYL-PYRROLIDINE-2-CARBOXAMIDE FORMUL 5 IFF C53 H62 BR F N8 O5 S FORMUL 6 HOH *100(H2 O) HELIX 1 AA1 THR A 23 LYS A 36 1 14 HELIX 2 AA2 PRO A 38 ASP A 40 5 3 HELIX 3 AA3 THR A 56 GLY A 61 1 6 HELIX 4 AA4 ARG B 33 LEU B 37 1 5 HELIX 5 AA5 SER B 39 LEU B 46 1 8 HELIX 6 AA6 PRO B 66 THR B 84 1 19 HELIX 7 AA7 ILE B 99 ASP B 111 1 13 HELIX 8 AA8 THR C 157 VAL C 170 1 14 HELIX 9 AA9 LYS C 171 LEU C 178 5 8 HELIX 10 AB1 VAL C 181 ASP C 190 1 10 HELIX 11 AB2 ASN C 193 GLN C 209 1 17 HELIX 12 AB3 PRO D 1380 TYR D 1397 1 18 HELIX 13 AB4 SER D 1406 ILE D 1410 5 5 HELIX 14 AB5 LEU D 1418 ILE D 1425 1 8 HELIX 15 AB6 ASP D 1430 ASN D 1440 1 11 HELIX 16 AB7 SER D 1445 ASN D 1464 1 20 HELIX 17 AB8 SER D 1468 LYS D 1490 1 23 SHEET 1 AA1 4 GLN A 49 LEU A 50 0 SHEET 2 AA1 4 GLN A 42 LYS A 46 -1 N LYS A 46 O GLN A 49 SHEET 3 AA1 4 ALA A 73 ALA A 81 -1 O GLY A 76 N TYR A 45 SHEET 4 AA1 4 THR A 84 PHE A 85 -1 O THR A 84 N ALA A 81 SHEET 1 AA2 8 GLN A 49 LEU A 50 0 SHEET 2 AA2 8 GLN A 42 LYS A 46 -1 N LYS A 46 O GLN A 49 SHEET 3 AA2 8 ALA A 73 ALA A 81 -1 O GLY A 76 N TYR A 45 SHEET 4 AA2 8 ASP A 2 ARG A 9 1 N ARG A 8 O VAL A 75 SHEET 5 AA2 8 THR A 12 LYS A 19 -1 O ALA A 18 N VAL A 3 SHEET 6 AA2 8 GLU B 28 LYS B 32 1 O ILE B 30 N THR A 13 SHEET 7 AA2 8 TYR B 18 ILE B 22 -1 N LEU B 21 O PHE B 29 SHEET 8 AA2 8 GLU B 59 ASN B 61 1 O VAL B 60 N ILE B 22 SHEET 1 AA3 4 THR C 105 TYR C 112 0 SHEET 2 AA3 4 PRO C 71 ASN C 78 -1 N VAL C 74 O ILE C 109 SHEET 3 AA3 4 ILE C 147 THR C 152 1 O ILE C 147 N ILE C 75 SHEET 4 AA3 4 LEU C 129 VAL C 130 -1 N LEU C 129 O THR C 152 SHEET 1 AA4 3 PRO C 95 PRO C 97 0 SHEET 2 AA4 3 VAL C 84 LEU C 89 -1 N TRP C 88 O GLN C 96 SHEET 3 AA4 3 LEU C 116 ASP C 121 -1 O LEU C 116 N LEU C 89 CRYST1 48.903 63.707 91.956 90.00 101.32 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020449 0.000000 0.004093 0.00000 SCALE2 0.000000 0.015697 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011091 0.00000